Chemical formula: C₁₆H₁₇N₇O₂S Molecular mass: 371.42 g/mol PubChem compound: 44205240
Baricitinib is indicated for:
Population group: only adults (18 - 65 years old)
Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with methotrexate.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Baricitinib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
